Saturated- and n-6 polyunsaturated-fat diets each induce ceramide accumulation in mouse skeletal muscle: reversal and improvement of glucose tolerance by lipid metabolism inhibitors.
about
The adipokine/ceramide axis: key aspects of insulin sensitizationLipidomics-Reshaping the Analysis and Perception of Type 2 Diabetes12- and 15-lipoxygenases in adipose tissue inflammationRole of ceramide in diabetes mellitus: evidence and mechanisms.Evidence for activation of inflammatory lipoxygenase pathways in visceral adipose tissue of obese Zucker rats.Ceramides and glucosylceramides are independent antagonists of insulin signalingDifferential regulation of dihydroceramide desaturase by palmitate versus monounsaturated fatty acids: implications for insulin resistancePlasma lipid profiling shows similar associations with prediabetes and type 2 diabetes.Effects of inhibition of serine palmitoyltransferase (SPT) and sphingosine kinase 1 (SphK1) on palmitate induced insulin resistance in L6 myotubesGenetic manipulation of cardiac Hsp72 levels does not alter substrate metabolism but reveals insights into high-fat feeding-induced cardiac insulin resistanceTargeting ceramide synthesis to reverse insulin resistance.TNF-α- and tumor-induced skeletal muscle atrophy involves sphingolipid metabolism.Role of ceramides in nonalcoholic fatty liver diseaseIncreased bioactive lipids content in human subcutaneous and epicardial fat tissue correlates with insulin resistanceSterol regulatory element-binding protein-1c mediates increase of postprandial stearic acid, a potential target for improving insulin resistance, in hyperlipidemia.Lipidomic risk score independently and cost-effectively predicts risk of future type 2 diabetes: results from diverse cohortsHepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasing de novo synthesis of long-chain ceramides.Sustained Action of Ceramide on the Insulin Signaling Pathway in Muscle Cells: IMPLICATION OF THE DOUBLE-STRANDED RNA-ACTIVATED PROTEIN KINASELipid-mediated muscle insulin resistance: different fat, different pathways?Lipidomics in the Study of Hypertension in Metabolic Syndrome.Adiponectin and its Hydrolase-Activated Receptors.Association of muscle lipidomic profile with high-fat diet-induced insulin resistance across five mouse strains.Mass and relative elution time profiling: two-dimensional analysis of sphingolipids in Alzheimer's disease brains.Ceramide accumulation in L6 skeletal muscle cells due to increased activity of ceramide synthase isoforms has opposing effects on insulin action to those caused by palmitate treatment.Decreasing high postprandial stearic acid in impaired fasting glucose by dietary regulation.
P2860
Q27025041-7F5902B1-419F-469E-8D4F-9D875203DAA1Q28073169-7834831E-CBE6-4A7E-83D8-D3FD11973091Q28274315-E69DE1E4-6C3A-4FAB-8B9C-102F05675490Q30351934-0AB07EB1-B3AD-4A50-8D0F-02E977D7B26FQ30429027-BEDBF6E6-71C5-4A15-AF58-57FE7E591521Q34384118-A88B2FCA-A1E5-486D-8509-66EA562E0BBDQ34947370-DDE2BC2D-6737-4DE7-9F29-DD8543D10C06Q35004985-02FC11E3-E020-47A4-A0F1-8010377758D9Q35078615-C040828E-664E-4D40-AA65-8CC8331F7DEFQ35529105-BA4DC816-B583-4EB8-B216-367499601A96Q35757184-E139936B-254B-4103-8C50-9A100E676BE3Q35935087-26FA3A7E-07E2-41E2-AA51-B857011D73E6Q36129432-470C56CF-BA16-4BD2-B4F3-1A0EEAF20F5DQ36408359-F7D45486-C565-486C-8498-68BE4B8C5B6FQ36560533-46C8F091-1918-44B4-AECE-65BACD7D24B3Q36765489-7FC1216B-DF73-4964-8D6C-D647786E3486Q37339555-F873EDDC-DE4D-4B11-A928-6473D9019A85Q38265601-54D7CEBB-74FA-4509-ACA9-2CADB8AD8DE6Q38537208-D9D980EC-2CD8-4A87-BCBC-FB27E966929AQ39123802-F93EB98B-73CF-4C62-81E1-0E60CF44F435Q41151107-DDEB3F09-0802-4ECB-A4E6-DD0931D56173Q42639375-BE72381D-BDA6-4819-9EB8-B40A2BD010DCQ44185145-A991E4FD-9700-428E-A537-0E504A20A1A7Q47671597-D77A7037-04B7-4BE0-A9B7-C391418E1F33Q51291368-430B987E-9C2E-4383-B539-D00BCEF369AB
P2860
Saturated- and n-6 polyunsaturated-fat diets each induce ceramide accumulation in mouse skeletal muscle: reversal and improvement of glucose tolerance by lipid metabolism inhibitors.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Saturated- and n-6 polyunsatur ...... y lipid metabolism inhibitors.
@ast
Saturated- and n-6 polyunsatur ...... y lipid metabolism inhibitors.
@en
Saturated- and n-6 polyunsatur ...... y lipid metabolism inhibitors.
@nl
type
label
Saturated- and n-6 polyunsatur ...... y lipid metabolism inhibitors.
@ast
Saturated- and n-6 polyunsatur ...... y lipid metabolism inhibitors.
@en
Saturated- and n-6 polyunsatur ...... y lipid metabolism inhibitors.
@nl
prefLabel
Saturated- and n-6 polyunsatur ...... y lipid metabolism inhibitors.
@ast
Saturated- and n-6 polyunsatur ...... y lipid metabolism inhibitors.
@en
Saturated- and n-6 polyunsatur ...... y lipid metabolism inhibitors.
@nl
P2093
P2860
P356
P1433
P1476
Saturated- and n-6 polyunsatur ...... y lipid metabolism inhibitors.
@en
P2093
C Schmitz-Peiffer
G Frangioudakis
J L Nadler
T W Mitchell
P2860
P304
P356
10.1210/EN.2010-0250
P407
P577
2010-07-21T00:00:00Z